
Docusign Inc. (NASDAQ:DOCU - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2027 earnings per share estimates for Docusign in a report issued on Thursday, June 26th. Zacks Research analyst R. Department now forecasts that the company will earn $0.24 per share for the quarter, down from their prior estimate of $0.28. The consensus estimate for Docusign's current full-year earnings is $1.17 per share.
Several other equities research analysts have also weighed in on DOCU. Morgan Stanley cut their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, June 6th. William Blair reaffirmed an "outperform" rating on shares of Docusign in a research note on Monday, April 21st. Citigroup reduced their target price on Docusign from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, June 9th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a report on Friday, June 6th. Finally, Jefferies Financial Group cut their price objective on Docusign from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, March 31st. Twelve investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Docusign has a consensus rating of "Hold" and a consensus target price of $89.77.
Read Our Latest Research Report on DOCU
Docusign Stock Up 2.4%
NASDAQ DOCU traded up $1.82 during trading on Monday, reaching $78.97. 1,921,092 shares of the stock traded hands, compared to its average volume of 2,857,764. Docusign has a fifty-two week low of $48.80 and a fifty-two week high of $107.86. The firm has a market cap of $15.96 billion, a price-to-earnings ratio of 14.93, a price-to-earnings-growth ratio of 28.87 and a beta of 1.08. The stock's 50-day moving average price is $82.33 and its 200 day moving average price is $84.82.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%. Docusign's revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.82 EPS.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Hemington Wealth Management grew its stake in shares of Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares in the last quarter. Banque Transatlantique SA bought a new position in shares of Docusign in the 1st quarter valued at about $26,000. Golden State Wealth Management LLC grew its position in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after acquiring an additional 322 shares during the period. Summit Securities Group LLC acquired a new position in shares of Docusign during the 1st quarter worth about $34,000. Finally, Wood Tarver Financial Group LLC bought a new stake in shares of Docusign in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 77.64% of the company's stock.
Insider Activity
In other news, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the completion of the transaction, the chief financial officer owned 110,723 shares in the company, valued at $8,282,080.40. This trade represents a 12.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Robert Chatwani sold 22,875 shares of Docusign stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the sale, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. This represents a 24.08% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 46,552 shares of company stock worth $3,491,951 over the last ninety days. Insiders own 1.01% of the company's stock.
Docusign declared that its board has approved a share repurchase program on Thursday, June 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.
About Docusign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.